RECRUITING

Adaptive Hip Exoskeleton for Stroke Gait Enhancement

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This work will focus on new algorithms for robotic exoskeletons and testing these in human subject tests. Individuals who have previously had a stroke will walk while wearing a robotic exoskeleton on a specialized treadmill as well as during other movement tasks (e.g. over ground, stairs, ramps). The study will compare the performance of the advanced algorithm with not using the device to determine the clinical benefit.

Official Title

Adaptive Hip Exoskeleton for Stroke Survivors With Gait Impairment

Quick Facts

Study Start:2025-05-21
Study Completion:2027-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05536739

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Between 18-85 years of age
  2. * Had a stroke at least 6 months prior to study involvement
  3. * Are community dwelling, which means the participant does not live in an assisted living facility
  4. * Are able to provide informed consent to participate in the study activities
  5. * Can safely participate in the study activities (per self-report)
  6. * Must have a Functional Ambulation Category (FAC) score of 3 or above, which means the participant can walk without the assistance of another person
  1. * Require a walker to walk independently
  2. * Have a shuffling gait pattern
  3. * Have a Functional Ambulation Category (FAC) score of 2 or lower, which means the participant requires the assistance of another person in order to walk
  4. * Have a significant secondary deficit beyond stroke (e.g. amputation, legal blindness or other severe impairment or condition) that in the opinion of the Principal Investigator (PI), would likely affect the study outcome or confound the results

Contacts and Locations

Study Contact

Aaron Young, Ph.D.
CONTACT
404-385-5306
aaron.young@me.gatech.edu
Kinsey R Herrin, MSPO, C/LPO
CONTACT
470-578-7600
kinsey.herrin@me.gatech.edu

Principal Investigator

Aaron Young, Ph.D.
PRINCIPAL_INVESTIGATOR
Georgia Institute of Technology

Study Locations (Sites)

Exoskeleton and Prosthetic Intelligent Controls Lab
Atlanta, Georgia, 30332
United States

Collaborators and Investigators

Sponsor: Georgia Institute of Technology

  • Aaron Young, Ph.D., PRINCIPAL_INVESTIGATOR, Georgia Institute of Technology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-21
Study Completion Date2027-07-31

Study Record Updates

Study Start Date2025-05-21
Study Completion Date2027-07-31

Terms related to this study

Keywords Provided by Researchers

  • Stroke

Additional Relevant MeSH Terms

  • Stroke